OB:BRGChemicals
Is Borregaard (OB:BRG) Fairly Valued As Cost Cuts Offset Impairment And Mixed Segment Results?
Mixed segment performance and impairment put Borregaard (OB:BRG) in focus
Borregaard (OB:BRG) has drawn investor attention after reporting stronger results in its BioMaterials and Fine Chemicals segments, softer performance in BioSolutions, and a NOK 337 million impairment on its investment in Alginor ASA.
At the same time, the company has launched a cost improvement programme targeting yearly savings of NOK 150 million by 2028. This adds a new element for investors to weigh alongside recent...